88 related articles for article (PubMed ID: 27513425)
1. Expression of maspin in testis tumors with germ cells andits relation with angiogenesis factors.
Çelik H; Turunç T; Bal N; Hasirci E; Akay A; Peşkircioğlu ÇL
Turk J Med Sci; 2016 Jun; 46(4):1197-202. PubMed ID: 27513425
[TBL] [Abstract][Full Text] [Related]
2. Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma.
Chua R; Setzer S; Govindarajan B; Sexton D; Cohen C; Arbiser JL
J Am Acad Dermatol; 2009 May; 60(5):758-66. PubMed ID: 19389518
[TBL] [Abstract][Full Text] [Related]
3. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.
Solomon LA; Munkarah AR; Schimp VL; Arabi MH; Morris RT; Nassar H; Ali-Fehmi R
Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262
[TBL] [Abstract][Full Text] [Related]
4. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF).
Cho JH; Kim HS; Park CS; Kim JK; Jung KY; Shin BK; Kim HK
Oral Oncol; 2007 Mar; 43(3):272-7. PubMed ID: 17174141
[TBL] [Abstract][Full Text] [Related]
5. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
6. Expression of maspin predicts poor prognosis in breast-cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Int J Cancer; 2002 Aug; 100(4):452-5. PubMed ID: 12115529
[TBL] [Abstract][Full Text] [Related]
7. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: an Izmir Oncology Group (IZOG) study.
Salman T; Yildiz E; Yildiz I; Yavuzer D; Unlu M; Varol U; Akyol M; Yildiz Y; Bayoglu V; Kucukzeybek Y; Alacacioglu A
J BUON; 2015; 20(4):1054-60. PubMed ID: 26416056
[TBL] [Abstract][Full Text] [Related]
9. Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications.
Lee DY; Park CS; Kim HS; Kim JY; Kim YC; Lee S
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):13-8. PubMed ID: 18091326
[TBL] [Abstract][Full Text] [Related]
10. [Expression of CD117 in human testicular germ cell tumors and its diagnostic value for seminoma and nonseminoma].
Liu DL; Lu YP; Shi HY; Zhu SX; Lü JW; Li WF; Rong X
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):38-41. PubMed ID: 18297810
[TBL] [Abstract][Full Text] [Related]
11. Possible predictive value of maspin expression in colorectal cancer.
Gurzu S; Szentirmay Z; Toth E; Jung I
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):183-90. PubMed ID: 22963136
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
13. [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma].
He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
15. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
16. [Expression of maspin and its relation to tumor vascularization in epithelian ovarian cancer].
Ma Y; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):223-7. PubMed ID: 19462894
[TBL] [Abstract][Full Text] [Related]
17. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
[TBL] [Abstract][Full Text] [Related]
18. Maspin expression in renal cell carcinoma and its correlation with clinicopathologic parameters.
Turunc T; Bal N; Dirim A; Kuzgunbay B; Gul U; Ozkardes H
Urology; 2010 Sep; 76(3):765.e8-13. PubMed ID: 20605199
[TBL] [Abstract][Full Text] [Related]
19. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression.
Datta MW; Macri E; Signoretti S; Renshaw AA; Loda M
Mod Pathol; 2001 May; 14(5):437-42. PubMed ID: 11353054
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease.
Fukuda S; Shirahama T; Imazono Y; Tsushima T; Ohmori H; Kayajima T; Take S; Nishiyama K; Yonezawa S; Akiba S; Akiyama S; Ohi Y
Cancer; 1999 Mar; 85(6):1323-30. PubMed ID: 10189138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]